POSACONAZOLE Side Effects

5913289-4 | Confusional State, Convulsion, Eye Injury, Fall, Headache, Laceration
on Oct 08, 2008 Female patient from UNITED STATES , 78 years of age, weighting 172.0 lb, was diagnosed with culture positive and was treated with Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: confusional state, convulsion, eye injury, fall (What is fall?), headache (What is headache?), laceration. Posaconazole dosage: 400mg Twice A Day Po, Not Sure Of Duration. Patient was hospitalized.

5859193-1 | Skin Exfoliation, Squamous Cell Carcinoma Of Skin
Patient was taking Posaconazole (View Usage). Patient had the following side effects: skin exfoliation, squamous cell carcinoma of skin on Aug 19, 2008 from IRELAND Additional patient health information: Male patient , 50 years of age, was diagnosed with fungal infection (What is fungal infection?) and. Posaconazole dosage: 400 Mg Bid Po. During the same period patient was treated with KEPPRA (View Keppra Review and Keppra Label ).

5831854-X | Blood Culture Positive, Haemosiderosis, Hepatic Fibrosis, Klebsiella Infection, Lung Neoplasm, Neutropenia, Scedosporium Infection, Sepsis, Stenotrophomonas Infection
Adverse event was reported on Jul 22, 2008 by a Male patient taking Posaconazole (View Usage) (Dosage: 200 Mg;tid;po) was diagnosed with antifungal prophylaxis and. Location: AUSTRALIA , 58 years of age, After Posaconazole was administered, patient had the following side effects: blood culture positive, haemosiderosis, hepatic fibrosis, klebsiella infection, lung neoplasm, neutropenia, scedosporium infection, sepsis (What is sepsis?), stenotrophomonas infection. During the same period patient was treated with CYCLOPHOSPHAMIDE (View Cyclophosphamide Review and Cyclophosphamide Label ), VINCRISTINE (View Vincristine Review and Vincristine Label ), DOXORUBICIN HCL (View Doxorubicin Hcl Review and Doxorubicin Hcl Label ), DEXAMETHASONE (View Dexamethasone Review and Dexamethasone Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ), CYTARABINE (View Cytarabine Review and Cytarabine Label ).

5812211-9 | Acute Myeloid Leukaemia Recurrent, Stem Cell Transplant
on Jul 06, 2008 Female patient from ISRAEL , 29 years of age, weighting 103.6 lb, was diagnosed with mucormycosis and was treated with Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia recurrent, stem cell transplant. Posaconazole dosage: 200 Gm; Bid.


5810386-9 | Acute Myeloid Leukaemia, Stem Cell Transplant
on Jul 03, 2008 Female patient from ISRAEL , 29 years of age, was diagnosed with mucormycosis and was treated with Posaconazole (View Usage). Patient had the following side effects: acute myeloid leukaemia, stem cell transplant. Posaconazole dosage: .

5704448-4 | Dizziness, Headache, Hypertension, Visual Disturbance
Patient was taking Posaconazole (View Usage). After Posaconazole was administered, patient had the following side effects: dizziness (What is dizziness?), headache (What is headache?), hypertension, visual disturbance on Apr 02, 2008 from FRANCE Additional patient health information: Female patient , 19 years of age, . Posaconazole dosage: ;po. During the same period patient was treated with NEORAL (160 Mg;qd;po) (View Neoral Review and Neoral Label ), CERTICAN (View Certican Review and Certican Label ). Patient was hospitalized.

5519100-8 | Abdominal Pain, Cardiac Failure
Adverse event was reported on Oct 30, 2007 by a Male patient taking Posaconazole (View Usage) (Dosage: 400 Mg; Qd; Iv, 300 Mg; Qd; Iv, 400 Mg; Bid; Po) . Location: GERMANY , 75 years of age, Patient experienced the following unwanted or unexpected effects: abdominal pain (What is abdominal pain?), cardiac failure. During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), BELOK ZOK MITE (View Belok Zok Mite Review and Belok Zok Mite Label ). Patient was hospitalized.

5518656-9 | Anxiety, Cardiac Arrest, Electrocardiogram Qt Prolonged, Hypomagnesaemia, Malaise, Overdose, Pyrexia, Thrombocytopenia, Torsade De Pointes
on Oct 25, 2007 Female patient from FRANCE , 14 years of age, weighting 163.1 lb, was diagnosed with mucormycosis, aspergillosis, nausea (What is nausea?) and was treated with Posaconazole (View Usage). Patient had the following side effects: anxiety (What is anxiety?), cardiac arrest (What is cardiac arrest?), electrocardiogram qt prolonged, hypomagnesaemia, malaise, overdose, pyrexia, thrombocytopenia, torsade de pointes. Posaconazole dosage: 200 Mg;po. During the same period patient was treated with VORICONAZOLE (VORICONAZOLE) (300 Mcg;iv) (View Voriconazole (voriconazole) Review and Voriconazole (voriconazole) Label ), OMEPRAZOLE (Po) (View Omeprazole Review and Omeprazole Label ), FORTUM (View Fortum Review and Fortum Label ), TARGOCID (View Targocid Review and Targocid Label ), CASPOFUNGIN ACETATE (View Caspofungin Acetate Review and Caspofungin Acetate Label ), ATARAX (View Atarax Review and Atarax Label ), POLARAMINE (View Polaramine Review and Polaramine Label ). Patient was hospitalized.

5460963-2 | Hepatic Enzyme Increased
on Apr 25, 2007 Male patient from UNITED STATES , weighting 14.55 lb, was diagnosed with fungal infection (What is fungal infection?) and was treated with Posaconazole (View Usage). After Posaconazole was administered, patient had the following side effects: hepatic enzyme increased. Posaconazole dosage: 60 Mg; Tid; Po; 30 Mg; Tid; Po. During the same period patient was treated with AMBISOME (View Ambisome Review and Ambisome Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

5449274-9 | Blood Culture Positive, Fungal Sepsis, Klebsiella Infection, Pathogen Resistance, Trichosporon Infection
Patient was taking Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: blood culture positive, fungal sepsis, klebsiella infection, pathogen resistance, trichosporon infection on Aug 28, 2007 from GERMANY Additional patient health information: Male patient , 68 years of age, was diagnosed with antifungal prophylaxis and. Posaconazole dosage: 200 Mg;tid ; 200 Mg;qid. During the same period patient was treated with ARA C (PREV.) (View Ara-c (prev.) Review and Ara-c (prev.) Label ), MITOXANTRON (PREV.) (View Mitoxantron (prev.) Review and Mitoxantron (prev.) Label ), DAUNORUBICIN (CON.) (View Daunorubicin (con.) Review and Daunorubicin (con.) Label ), THIOGUANINE (CON.) (View Thioguanine (con.) Review and Thioguanine (con.) Label ), CYTARABINE (CON.) (View Cytarabine (con.) Review and Cytarabine (con.) Label ), PIPERACILLIN (CON.) (View Piperacillin (con.) Review and Piperacillin (con.) Label ), TAZOBACTAM (CON.) (View Tazobactam (con.) Review and Tazobactam (con.) Label ).

5448644-2 | Vision Blurred
Adverse event was reported on Sep 07, 2007 by a Female patient taking Posaconazole (View Usage) (Dosage: 200 Mg Po Tid) . Location: UNITED STATES , 60 years of age, Patient had the following side effects: vision blurred. During the same period patient was treated with MICAFUNGIN (View Micafungin Review and Micafungin Label ), LEVOTHYROXINE SODIUM (View Levothyroxine Sodium Review and Levothyroxine Sodium Label ), PREDNISONE (View Prednisone Review and Prednisone Label ), BACTRIM (View Bactrim Review and Bactrim Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), MULTI VITAMIN (View Multi-vitamin Review and Multi-vitamin Label ), CALCIUM WITH VITAMIN D (View Calcium With Vitamin D Review and Calcium With Vitamin D Label ), DARBEPOETIN (View Darbepoetin Review and Darbepoetin Label ).

5355219-2 | Hepatic Enzyme Increased
on Apr 25, 2007 Male patient from UNITED STATES , weighting 14.55 lb, was diagnosed with fungal infection (What is fungal infection?) and was treated with Posaconazole (View Usage). After Posaconazole was administered, patient had the following side effects: hepatic enzyme increased. Posaconazole dosage: See Image. During the same period patient was treated with AMBISOME (View Ambisome Review and Ambisome Label ), ETOPOSIDE (View Etoposide Review and Etoposide Label ), DEXAMETHASONE 0.5MG TAB (View Dexamethasone 0.5mg Tab Review and Dexamethasone 0.5mg Tab Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ).

5353175-4 | Acute Myeloid Leukaemia Recurrent, Cardio-respiratory Arrest, Dehydration, Nausea, Pyrexia
on Jun 05, 2007 Female patient from UNITED STATES , 61 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: acute myeloid leukaemia recurrent, cardio-respiratory arrest, dehydration, nausea (What is nausea?), pyrexia. Posaconazole dosage: 400 Mg;bid;po. Patient was hospitalized.

5331085-6 | Bacterial Sepsis
Patient was taking Posaconazole (View Usage). Patient had the following side effects: bacterial sepsis on May 08, 2007 from GERMANY Additional patient health information: Male patient , 71 years of age, weighting 176.4 lb, was diagnosed with antifungal prophylaxis and. Posaconazole dosage: Qd. During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), PRIMAXIN (View Primaxin Review and Primaxin Label ), VANCOMYCIN HCL (View Vancomycin Hcl Review and Vancomycin Hcl Label ), TAZOBAC (View Tazobac Review and Tazobac Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

5326536-7 | Alanine Aminotransferase Increased, Aspartate Aminotransferase Increased, Blood Alkaline Phosphatase Increased, Cholelithiasis, Dehydration, Hyperbilirubinaemia, Hypoalbuminaemia, Hypotension, Oral Intake Reduced
Adverse event was reported on May 04, 2007 by a Male patient taking Posaconazole (View Usage) (Dosage: 400 Mg; Bid; Po) was diagnosed with fungal infection (What is fungal infection?) and. Location: UNITED STATES , 20 years of age, weighting 123.5 lb, After Posaconazole was administered, patient had the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, cholelithiasis, dehydration, hyperbilirubinaemia, hypoalbuminaemia, hypotension, oral intake reduced. During the same period patient was treated with ZENERGAN (ZONISAMIDE) (View Zenergan (zonisamide) Review and Zenergan (zonisamide) Label ), DEPAKENE (View Depakene Review and Depakene Label ), MEGACE (View Megace Review and Megace Label ), FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PREVACID (View Prevacid Review and Prevacid Label ). Patient was hospitalized.

5325810-8 | Bacterial Sepsis, Pyrexia
on Apr 30, 2007 Male patient from GERMANY , 71 years of age, weighting 176.4 lb, was diagnosed with antifungal prophylaxis and was treated with Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: bacterial sepsis, pyrexia. Posaconazole dosage: Qd. During the same period patient was treated with CYTARABINE (View Cytarabine Review and Cytarabine Label ), DAUNORUBICIN HCL (View Daunorubicin Hcl Review and Daunorubicin Hcl Label ), PRIMAXIN (View Primaxin Review and Primaxin Label ), VANCOMYCIN (View Vancomycin Review and Vancomycin Label ), TAZOBAC (View Tazobac Review and Tazobac Label ), GENTAMICIN (View Gentamicin Review and Gentamicin Label ). Patient was hospitalized.

5325755-3 | Atrial Fibrillation, Atrioventricular Block First Degree, Blood Culture Positive, Blood Pressure Decreased, Cardiac Failure Congestive, Diphtheria, Fluid Overload, Infected Skin Ulcer, Left Atrial Dilatation
on May 01, 2007 Male patient from UNITED STATES , 43 years of age, weighting 156.0 lb, was diagnosed with fungal infection (What is fungal infection?) and was treated with Posaconazole (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), atrioventricular block first degree, blood culture positive, blood pressure decreased, cardiac failure congestive, diphtheria (What is diphtheria?), fluid overload, infected skin ulcer, left atrial dilatation. Posaconazole dosage: 400 Mg; Bid; Po. During the same period patient was treated with REGLAN (CON.) (View Reglan (con.) Review and Reglan (con.) Label ), SYNTHROID (CON.) (View Synthroid (con.) Review and Synthroid (con.) Label ), MEGACE (CON.) (View Megace (con.) Review and Megace (con.) Label ), LISINOPRIL (CON.) (View Lisinopril (con.) Review and Lisinopril (con.) Label ), PROTONIX (PANTOPRAZOLE SODIUM) (CON.) (View Protonix (pantoprazole Sodium) (con.) Review and Protonix (pantoprazole Sodium) (con.) Label ), PREDNISONE (CON.) (View Prednisone (con.) Review and Prednisone (con.) Label ), PHOS LO (CON.) (View Phos Lo (con.) Review and Phos Lo (con.) Label ), LANTUS (INSULIN GLARGINE) (CON.) (View Lantus (insulin Glargine) (con.) Review and Lantus (insulin Glargine) (con.) Label ). Patient was hospitalized.

5323102-4 | Acute Graft Versus Host Disease In Intestine, Acute Graft Versus Host Disease In Skin, Cholelithiasis, Cholestasis, Constipation, Convulsion, Cystitis, Cytomegalovirus Infection, Dehydration
Patient was taking Posaconazole (View Usage). After Posaconazole was administered, patient had the following side effects: acute graft versus host disease in intestine, acute graft versus host disease in skin, cholelithiasis, cholestasis, constipation (What is constipation?), convulsion, cystitis, cytomegalovirus infection (What is cytomegalovirus infection?), dehydration on Apr 23, 2007 from GERMANY Additional patient health information: Male patient , 61 years of age, weighting 174.2 lb, was diagnosed with fungal infection (What is fungal infection?), prophylaxis against graft versus host disease, antiviral prophylaxis and. Posaconazole dosage: 200 Mg; Qid; Po. During the same period patient was treated with PROGRAF (4 Mg; Po) (View Prograf Review and Prograf Label ), ACYCLOVIR (200 Mg; Bid; Po) (View Acyclovir Review and Acyclovir Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), DECORTIN (View Decortin Review and Decortin Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ), BELOC ZOC COMP (View Beloc Zoc Comp Review and Beloc Zoc Comp Label ). Patient was hospitalized.

5321088-X | Electrocardiogram Qt Corrected Interval Prolonged, Palpitations, Tachyarrhythmia
Adverse event was reported on Apr 24, 2007 by a Female patient taking Posaconazole (View Usage) (Dosage: 400 Mg; Bid; Po) was diagnosed with fungal infection (What is fungal infection?) and. Location: UNITED STATES , 17 years of age, weighting 185.2 lb, Patient experienced the following unwanted or unexpected effects: electrocardiogram qt corrected interval prolonged, palpitations, tachyarrhythmia. During the same period patient was treated with EPINEPHRINE (.5 Mgl; Once; Sc) (View Epinephrine Review and Epinephrine Label ). Patient was hospitalized.

5316289-0 | Acute Myeloid Leukaemia Recurrent, Dehydration, Nausea, Pyrexia
on Apr 16, 2007 Female patient from UNITED STATES , 61 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Posaconazole (View Usage). Patient had the following side effects: acute myeloid leukaemia recurrent, dehydration, nausea (What is nausea?), pyrexia. Posaconazole dosage: 400 Mg; Bid; Po. Patient was hospitalized.

5314766-X | Abdominal Pain, Cardiac Failure
on Apr 11, 2007 Male patient from GERMANY , 75 years of age, was treated with Posaconazole (View Usage). After Posaconazole was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), cardiac failure. Posaconazole dosage: 300 Mg; Qd; Iv. During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), BELOK ZOK MITE (View Belok Zok Mite Review and Belok Zok Mite Label ). Patient was hospitalized.

5291416-2 | Cardio-respiratory Arrest, Lung Infection, Pulmonary Haemorrhage, Zygomycosis
Patient was taking Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: cardio-respiratory arrest, lung infection, pulmonary haemorrhage, zygomycosis on Mar 19, 2007 from CANADA Additional patient health information: Male patient , weighting 131.8 lb, was diagnosed with fungal infection (What is fungal infection?) and. Posaconazole dosage: 400 Mg;bid;po. During the same period patient was treated with CODEINE (View Codeine Review and Codeine Label ), ATARAX (View Atarax Review and Atarax Label ), LORAZEPAM (View Lorazepam Review and Lorazepam Label ), K LYTE (View K-lyte Review and K-lyte Label ), OLANZAPINE (View Olanzapine Review and Olanzapine Label ), BENADRYL (View Benadryl Review and Benadryl Label ), LINEZOLID (View Linezolid Review and Linezolid Label ), CIPROFLOXACIN (View Ciprofloxacin Review and Ciprofloxacin Label ). Patient was hospitalized.

5285017-X | Bradycardia, Bradypnoea, Cerebral Disorder, Coma, Condition Aggravated, Hepatic Enzyme Increased, Hypotension, Liver Disorder, Respiratory Failure
Adverse event was reported on Mar 20, 2007 by a Male patient taking Posaconazole (View Usage) (Dosage: 400 Mg;bid;po) was diagnosed with fungal infection (What is fungal infection?), pain (What is pain?), antiviral prophylaxis, pneumonia (What is pneumonia?), sedation and. Location: SWITZERLAND , 48 years of age, weighting 216.1 lb, Patient had the following side effects: bradycardia, bradypnoea, cerebral disorder, coma, condition aggravated, hepatic enzyme increased, hypotension, liver disorder, respiratory failure. During the same period patient was treated with MORPHINE (Iv) (View Morphine Review and Morphine Label ), ACYCLOVIR (750 Mg; Iv) (View Acyclovir Review and Acyclovir Label ), TAXOBACTAM/PIPERACILLIN (NO PREF. NAME) (4.5 Gm;tid) (View Taxobactam/piperacillin (no Pref. Name) Review and Taxobactam/piperacillin (no Pref. Name) Label ), PROPOFOL (Iv) (View Propofol Review and Propofol Label ), ABELCET (View Abelcet Review and Abelcet Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ). Patient was hospitalized.

5282611-7 | Atelectasis, Blood Albumin Decreased, Blood Potassium Decreased, Cardiac Failure Congestive, Chronic Obstructive Pulmonary Disease, Condition Aggravated, Fibrin D Dimer Increased, Haematocrit Decreased, Haemoglobin Decreased
on Mar 13, 2007 Female patient from UNITED STATES , 67 years of age, weighting 143.0 lb, was diagnosed with systemic mycosis and was treated with Posaconazole (View Usage). After Posaconazole was administered, patient had the following side effects: atelectasis, blood albumin decreased, blood potassium decreased, cardiac failure congestive, chronic obstructive pulmonary disease, condition aggravated, fibrin d dimer increased, haematocrit decreased, haemoglobin decreased. Posaconazole dosage: 400 Mg; Bid. During the same period patient was treated with CIPROFLOXACIN (250 Mg; Bid) (View Ciprofloxacin Review and Ciprofloxacin Label ), ATENOLOL (View Atenolol Review and Atenolol Label ), AVANDIA (View Avandia Review and Avandia Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ALBUTEROL SULFATE (View Albuterol Sulfate Review and Albuterol Sulfate Label ), FISH OIL (View Fish Oil Review and Fish Oil Label ), GLYBURIDE (View Glyburide Review and Glyburide Label ). Patient was hospitalized.

5271124-4 | Arteriosclerosis, Arteriosclerosis Coronary Artery, Bradycardia, Bradypnoea, Brain Stem Syndrome, Cardiovascular Disorder, Cerebral Disorder, Coma, Condition Aggravated
on Mar 02, 2007 Male patient from SWITZERLAND , 48 years of age, weighting 216.1 lb, was diagnosed with sinusitis fungal, pain (What is pain?), herpes virus infection, prophylaxis, pneumonia (What is pneumonia?), sedation and was treated with Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: arteriosclerosis, arteriosclerosis coronary artery, bradycardia, bradypnoea, brain stem syndrome, cardiovascular disorder, cerebral disorder, coma, condition aggravated. Posaconazole dosage: 400 Mg; Bid; Po. During the same period patient was treated with MORPHINE (See Image) (View Morphine Review and Morphine Label ), ACYCLOVIR (750 Mg; Iv) (View Acyclovir Review and Acyclovir Label ), TAXOBACTAM/PIPERACILLIN (NO PREF. NAME) (4.5 Gm; Tid) (View Taxobactam/piperacillin (no Pref. Name) Review and Taxobactam/piperacillin (no Pref. Name) Label ), PROPOFOL (Iv) (View Propofol Review and Propofol Label ), ABELCET (View Abelcet Review and Abelcet Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), DIFLUCAN (View Diflucan Review and Diflucan Label ). Patient was hospitalized.

5254741-7 | Stem Cell Transplant
Patient was taking Posaconazole (View Usage). Patient had the following side effects: stem cell transplant on Feb 12, 2007 from UNITED STATES Additional patient health information: Male patient , 51 years of age, was diagnosed with zygomycosis and. Posaconazole dosage: See Image. During the same period patient was treated with AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ).

5252063-1 | Abdominal Pain, Cardiac Failure
Adverse event was reported on Feb 09, 2007 by a Male patient taking Posaconazole (View Usage) (Dosage: 300 Mg Qd Iv) . Location: GERMANY , 75 years of age, After Posaconazole was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), cardiac failure. During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ), BELOK ZOK MITE (View Belok Zok Mite Review and Belok Zok Mite Label ). Patient was hospitalized.

5251992-2 | Gastrointestinal Haemorrhage, Haemoglobin Decreased, Haemolytic Uraemic Syndrome, Intra-abdominal Haemorrhage, Multi-organ Failure, Thrombotic Thrombocytopenic Purpura
on Feb 12, 2007 Male patient from CANADA , 20 years of age, weighting 152.1 lb, was diagnosed with prophylaxis and was treated with Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: gastrointestinal haemorrhage, haemoglobin decreased, haemolytic uraemic syndrome, intra-abdominal haemorrhage, multi-organ failure, thrombotic thrombocytopenic purpura. Posaconazole dosage: 200 Mg; Tid; Po. During the same period patient was treated with FOLIC ACID (View Folic Acid Review and Folic Acid Label ), PENICILLIN V POTASSIUM (View Penicillin V Potassium Review and Penicillin V Potassium Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), BENADRYL (View Benadryl Review and Benadryl Label ), HYDROCORTISONE (S P) (View Hydrocortisone (s-p) Review and Hydrocortisone (s-p) Label ), URSO (View Urso Review and Urso Label ), IMURAN (View Imuran Review and Imuran Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ). Patient was hospitalized.

5243841-3 | Blood Alkaline Phosphatase Increased, Bronchitis, Disease Progression, Hypercapnia, Lung Neoplasm, Nausea, Pleuritic Pain, Pneumonia, Pulmonary Mycosis
on Feb 01, 2007 Female patient from BELGIUM , 30 years of age, weighting 110.2 lb, was diagnosed with fungal infection (What is fungal infection?), pleuritic pain and was treated with Posaconazole (View Usage). Patient had the following side effects: blood alkaline phosphatase increased, bronchitis (What is bronchitis?), disease progression, hypercapnia, lung neoplasm, nausea (What is nausea?), pleuritic pain, pneumonia (What is pneumonia?), pulmonary mycosis. Posaconazole dosage: See Image. During the same period patient was treated with MORPHINE (See Image) (View Morphine Review and Morphine Label ), AMBISON (AMPHOTERICIN B) (View Ambison (amphotericin B) Review and Ambison (amphotericin B) Label ), NEORAL (View Neoral Review and Neoral Label ). Patient was hospitalized.

5237950-2 | Haematocrit Decreased, Haemoglobin Decreased, Monocyte Percentage Increased, Neutrophil Percentage Decreased, Red Blood Cell Count Decreased, Upper Gastrointestinal Haemorrhage
Patient was taking Posaconazole (View Usage). After Posaconazole was administered, patient had the following side effects: haematocrit decreased, haemoglobin decreased, monocyte percentage increased, neutrophil percentage decreased, red blood cell count decreased, upper gastrointestinal haemorrhage on Jan 30, 2007 from MALAYSIA Additional patient health information: Male patient , 41 years of age, weighting 110.2 lb, was diagnosed with fungal sepsis and. Posaconazole dosage: 200 Mg; Qid; Po. During the same period patient was treated with IMIPENEM (View Imipenem Review and Imipenem Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DAFLON (View Daflon Review and Daflon Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ). Patient was hospitalized.

5237881-8 |
Adverse event was reported on Jan 31, 2007 by a Female patient taking Posaconazole (View Usage) (Dosage: ) . Location: UNITED STATES , 58 years of age, .

5228823-X |
on Dec 12, 2006 Female patient from UNITED STATES , 58 years of age, was treated with Posaconazole (View Usage). . Posaconazole dosage: .

5220124-9 | Oedema Peripheral
on Jan 25, 2007 Female patient from UNITED STATES , 29 years of age, weighting 260.1 lb, was diagnosed with fungal skin infection and was treated with Posaconazole (View Usage). After Posaconazole was administered, patient had the following side effects: oedema peripheral. Posaconazole dosage: 200mg Qid Po.

5215233-4 | Blood Alkaline Phosphatase Increased, Bronchitis, Disease Progression, Hypercapnia, Lung Neoplasm, Nausea, Pleuritic Pain, Pneumonia, Respiratory Failure
Patient was taking Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, bronchitis (What is bronchitis?), disease progression, hypercapnia, lung neoplasm, nausea (What is nausea?), pleuritic pain, pneumonia (What is pneumonia?), respiratory failure on Jan 08, 2007 from BELGIUM Additional patient health information: Female patient , 30 years of age, weighting 110.2 lb, was diagnosed with fungal infection (What is fungal infection?), pleuritic pain and. Posaconazole dosage: See Imgae. During the same period patient was treated with MORPHINE (See Image) (View Morphine Review and Morphine Label ), AMBISOME (View Ambisome Review and Ambisome Label ), NEORAL (View Neoral Review and Neoral Label ), TPN (View Tpn Review and Tpn Label ). Patient was hospitalized.

5209733-0 | Haematocrit Decreased, Haemoglobin Decreased, Multi-organ Failure, Pneumonia
Adverse event was reported on Dec 27, 2006 by a Male patient taking Posaconazole (View Usage) (Dosage: 400 Mg; Iv; 300 Mg; Iv; 400 Mg; Iv-see Image) was diagnosed with prophylaxis and. Location: BELGIUM , 48 years of age, weighting 158.7 lb, Patient had the following side effects: haematocrit decreased, haemoglobin decreased, multi-organ failure, pneumonia (What is pneumonia?). Patient was hospitalized.

5208057-5 | Abdominal Pain, Cardiac Failure
on Dec 28, 2006 Male patient from GERMANY , 75 years of age, was treated with Posaconazole (View Usage). After Posaconazole was administered, patient had the following side effects: abdominal pain (What is abdominal pain?), cardiac failure. Posaconazole dosage: 300 Mg, Qd; Iv. During the same period patient was treated with METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), POTASSIUM CHLORIDE (View Potassium Chloride Review and Potassium Chloride Label ), RAMIPRIL (View Ramipril Review and Ramipril Label ). Patient was hospitalized.

5208042-3 | Haematocrit Decreased, Haemoglobin Decreased, Haemorrhoids, Platelet Count Decreased, Red Blood Cell Count Decreased, Upper Gastrointestinal Haemorrhage
on Dec 26, 2006 Male patient from MALAYSIA , 41 years of age, weighting 110.2 lb, was diagnosed with fusarium infection, sepsis (What is sepsis?) and was treated with Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: haematocrit decreased, haemoglobin decreased, haemorrhoids, platelet count decreased, red blood cell count decreased, upper gastrointestinal haemorrhage. Posaconazole dosage: 200 Mg, Qid; Po. During the same period patient was treated with IMIPENEM (View Imipenem Review and Imipenem Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ), OMEPRAZOLE (View Omeprazole Review and Omeprazole Label ), DAFLON (View Daflon Review and Daflon Label ), IMMUNE GLOBULIN INTRAVENOUS (HUMAN) (View Immune Globulin Intravenous (human) Review and Immune Globulin Intravenous (human) Label ). Patient was hospitalized.

5199526-5 | Haematocrit Decreased, Haemoglobin Decreased, Pneumonia, Respiratory Distress
Patient was taking Posaconazole (View Usage). Patient had the following side effects: haematocrit decreased, haemoglobin decreased, pneumonia (What is pneumonia?), respiratory distress on Dec 19, 2006 from BELGIUM Additional patient health information: Male patient , 48 years of age, weighting 158.7 lb, was diagnosed with prophylaxis and. Posaconazole dosage: 300 Mg; Qd. Patient was hospitalized.

5182667-6 | Capillary Leak Syndrome, Leukopenia, Palmar-plantar Erythrodysaesthesia Syndrome
Adverse event was reported on Nov 29, 2006 by a Male patient taking Posaconazole (View Usage) (Dosage: ) was diagnosed with aspergillosis, acute lymphocytic leukaemia and. Location: UNITED STATES , 30 years of age, After Posaconazole was administered, patient had the following side effects: capillary leak syndrome, leukopenia, palmar-plantar erythrodysaesthesia syndrome. During the same period patient was treated with CLOFARABINE (View Clofarabine Review and Clofarabine Label ). Patient was hospitalized.

5179512-1 | Acute Graft Versus Host Disease In Liver, Acute Graft Versus Host Disease In Skin, Catheter Related Infection, Haemolytic Anaemia, Pneumonia, Polyneuropathy, Renal Failure Acute, Respiratory Failure
on Nov 23, 2006 Female patient from GERMANY , 50 years of age, was diagnosed with neutropenia and was treated with Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: acute graft versus host disease in liver, acute graft versus host disease in skin, catheter related infection, haemolytic anaemia, pneumonia (What is pneumonia?), polyneuropathy, renal failure acute, respiratory failure. Posaconazole dosage: See Image. Patient was hospitalized.

5170150-3 | Disease Progression, Fungal Skin Infection, Scedosporium Infection, Shock
on Dec 04, 2006 Male patient from BELGIUM , 32 years of age, was diagnosed with fungal skin infection, scedosporium infection and was treated with Posaconazole (View Usage). Patient had the following side effects: disease progression, fungal skin infection, scedosporium infection, shock. Posaconazole dosage: 800 Mg; Qd; Po. During the same period patient was treated with SYMBICORT (View Symbicort Review and Symbicort Label ), DURAGESIC 100 (View Duragesic-100 Review and Duragesic-100 Label ), XANAX (View Xanax Review and Xanax Label ), MOXON (View Moxon Review and Moxon Label ), PERINDOPRIL ERBUMINE (View Perindopril Erbumine Review and Perindopril Erbumine Label ), LANTUS (View Lantus Review and Lantus Label ), NOVORAPID (View Novorapid Review and Novorapid Label ).

5167462-6 | Blood Alkaline Phosphatase Increased, Bronchitis, Disease Progression, Hypercapnia, Lung Neoplasm, Nausea, Pneumonia, Respiratory Failure, Stenotrophomonas Infection
Patient was taking Posaconazole (View Usage). After Posaconazole was administered, patient had the following side effects: blood alkaline phosphatase increased, bronchitis (What is bronchitis?), disease progression, hypercapnia, lung neoplasm, nausea (What is nausea?), pneumonia (What is pneumonia?), respiratory failure, stenotrophomonas infection on Nov 20, 2006 from BELGIUM Additional patient health information: Female patient , 30 years of age, weighting 110.2 lb, was diagnosed with fungal infection (What is fungal infection?), pleuritic pain and. Posaconazole dosage: See Image. During the same period patient was treated with MORPHINE (See Image) (View Morphine Review and Morphine Label ), AMBISOME (View Ambisome Review and Ambisome Label ), NEORAL (CON.) (View Neoral (con.) Review and Neoral (con.) Label ), PARENTERAL NUTRITION (CON.) (View Parenteral Nutrition (con.) Review and Parenteral Nutrition (con.) Label ), MEDROL (CON.) (View Medrol (con.) Review and Medrol (con.) Label ). Patient was hospitalized.

5165182-5 | Blood Alkaline Phosphatase Increased, Bronchitis, Disease Progression, Hypercapnia, Nausea, Pleuritic Pain, Pneumonia, Respiratory Failure, Stenotrophomonas Infection
Adverse event was reported on Nov 20, 2006 by a Female patient taking Posaconazole (View Usage) (Dosage: 200 Mg Qid Po ; 400 Mg Bid ; 200 Mg Qid ; 200 Mg Bid) was diagnosed with fungal infection (What is fungal infection?), pleuritic pain and. Location: BELGIUM , 30 years of age, weighting 110.2 lb, Patient experienced the following unwanted or unexpected effects: blood alkaline phosphatase increased, bronchitis (What is bronchitis?), disease progression, hypercapnia, nausea (What is nausea?), pleuritic pain, pneumonia (What is pneumonia?), respiratory failure, stenotrophomonas infection. During the same period patient was treated with MORPHINE (Sc ; Iv) (View Morphine Review and Morphine Label ), NEOROL (View Neorol Review and Neorol Label ), TPN (View Tpn Review and Tpn Label ), MEDROL (View Medrol Review and Medrol Label ). Patient was hospitalized.

5162112-7 | Bacterial Infection, Blood Alkaline Phosphatase Increased, Bronchitis, Disease Progression, Fungal Infection, Hypercapnia, Lung Infiltration, Nausea, Nodule
on Nov 07, 2006 Female patient from BELGIUM , 30 years of age, weighting 110.2 lb, was diagnosed with fungal infection (What is fungal infection?), pleuritic pain and was treated with Posaconazole (View Usage). Patient had the following side effects: bacterial infection (What is bacterial infection?), blood alkaline phosphatase increased, bronchitis (What is bronchitis?), disease progression, fungal infection (What is fungal infection?), hypercapnia, lung infiltration, nausea (What is nausea?), nodule. Posaconazole dosage: See Image. During the same period patient was treated with MORPHINE (See Image) (View Morphine Review and Morphine Label ), AMBISOME (View Ambisome Review and Ambisome Label ), NEORAL (View Neoral Review and Neoral Label ), TPN (View Tpn Review and Tpn Label ). Patient was hospitalized.

5153632-X | Bacterial Sepsis, Benign Prostatic Hyperplasia, Blood Disorder, Cardiac Failure, Cholelithiasis, Cholestasis, Condition Aggravated, Constipation, Convulsion
on Oct 30, 2006 Male patient from GERMANY , 61 years of age, weighting 174.2 lb, was diagnosed with fungal infection (What is fungal infection?), prophylaxis against graft versus host disease, antiviral prophylaxis and was treated with Posaconazole (View Usage). After Posaconazole was administered, patient had the following side effects: bacterial sepsis, benign prostatic hyperplasia, blood disorder, cardiac failure, cholelithiasis, cholestasis, condition aggravated, constipation (What is constipation?), convulsion. Posaconazole dosage: 200 Mg;qid;po. During the same period patient was treated with PROGRAF (4 Mg;po) (View Prograf Review and Prograf Label ), ACYCLOVIR (200 Mg;bid;po) (View Acyclovir Review and Acyclovir Label ), SANDIMMUNE (View Sandimmune Review and Sandimmune Label ), DECORTIN (View Decortin Review and Decortin Label ), GANCICLOVIR (View Ganciclovir Review and Ganciclovir Label ), CELLCEPT (View Cellcept Review and Cellcept Label ), BELOC ZOC COMP (View Beloc Zoc Comp Review and Beloc Zoc Comp Label ). Patient was hospitalized.

5148250-3 | Lung Infiltration, Respiratory Failure
Patient was taking Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: lung infiltration, respiratory failure on Aug 22, 2006 from GERMANY Additional patient health information: Female patient , 50 years of age, was diagnosed with neutropenia and. Posaconazole dosage: See Image. During the same period patient was treated with . (View . Review and . Label ). Patient was hospitalized.

5147342-2 | Atrial Fibrillation, Atrioventricular Block First Degree, Blood Pressure Decreased, Cardiac Failure Congestive, Dilatation Atrial, Fluid Overload, Fungal Infection, Infected Skin Ulcer, Mitral Valve Incompetence
Adverse event was reported on Oct 16, 2006 by a Male patient taking Posaconazole (View Usage) (Dosage: 400 Mg; Bid; Po) was diagnosed with fungal infection (What is fungal infection?) and. Location: UNITED STATES , 43 years of age, weighting 156.0 lb, Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), atrioventricular block first degree, blood pressure decreased, cardiac failure congestive, dilatation atrial, fluid overload, fungal infection (What is fungal infection?), infected skin ulcer, mitral valve incompetence. During the same period patient was treated with REGLAN (View Reglan Review and Reglan Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), MEGACE (View Megace Review and Megace Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), PROTONIX (View Protonix Review and Protonix Label ), PREDNISONE TAB (View Prednisone Tab Review and Prednisone Tab Label ), PHOSLO (View Phoslo Review and Phoslo Label ), LANTUS (View Lantus Review and Lantus Label ). Patient was hospitalized.

5141161-9 | Blood Alkaline Phosphatase Increased, Bronchitis, Disease Progression, Hepatic Enzyme Increased, Hypercapnia, Lung Neoplasm, Nausea, Pleuritic Pain, Pneumonia Fungal
on Oct 06, 2006 Female patient from BELGIUM , 30 years of age, weighting 110.2 lb, was diagnosed with fungal infection (What is fungal infection?), pleuritic pain and was treated with Posaconazole (View Usage). After Posaconazole was administered, patient had the following side effects: blood alkaline phosphatase increased, bronchitis (What is bronchitis?), disease progression, hepatic enzyme increased, hypercapnia, lung neoplasm, nausea (What is nausea?), pleuritic pain, pneumonia fungal. Posaconazole dosage: See Image. During the same period patient was treated with MORPHINE (See Image) (View Morphine Review and Morphine Label ), AMBISOME (View Ambisome Review and Ambisome Label ), NEORAL (View Neoral Review and Neoral Label ), TPN (View Tpn Review and Tpn Label ). Patient was hospitalized.

5139691-9 | Ascites, Aspergillosis, Blood Disorder, Blood Pressure Decreased, Bronchitis, Coma, Culture Urine Positive, Cytolytic Hepatitis, Disease Progression
on Oct 06, 2006 Female patient from FRANCE , 40 years of age, was diagnosed with fungal infection (What is fungal infection?) and was treated with Posaconazole (View Usage). Patient experienced the following unwanted or unexpected effects: ascites, aspergillosis, blood disorder, blood pressure decreased, bronchitis (What is bronchitis?), coma, culture urine positive, cytolytic hepatitis, disease progression. Posaconazole dosage: 400 Mg; Bid; Po. During the same period patient was treated with EFFEXOR (View Effexor Review and Effexor Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), ROCEPHIN (View Rocephin Review and Rocephin Label ), CIFLOX (View Ciflox Review and Ciflox Label ), VITAMIN CAP (View Vitamin Cap Review and Vitamin Cap Label ), HUMAN RED BLOOD CELLS (View Human Red Blood Cells Review and Human Red Blood Cells Label ), PLATELETS (View Platelets Review and Platelets Label ), POLARAMINE (View Polaramine Review and Polaramine Label ). Patient was hospitalized.

5136019-5 | Adenovirus Infection, Multi-organ Failure, Stem Cell Transplant, Transplant Rejection
Patient was taking Posaconazole (View Usage). Patient had the following side effects: adenovirus infection, multi-organ failure, stem cell transplant, transplant rejection on Sep 21, 2006 from GERMANY Additional patient health information: Female patient , child 10 years of age, was diagnosed with fungal infection (What is fungal infection?) and. Posaconazole dosage: 200 Mg; Qid; Po. During the same period patient was treated with METHYLPREDNISOLONE 4MG TAB (View Methylprednisolone 4mg Tab Review and Methylprednisolone 4mg Tab Label ), CYCLOSPORINE (View Cyclosporine Review and Cyclosporine Label ), ATGAM (View Atgam Review and Atgam Label ), FLUCONAZOLE (View Fluconazole Review and Fluconazole Label ), TRIMETHOPRIM + SULFAMETHOXAZOLE (View Trimethoprim + Sulfamethoxazole Review and Trimethoprim + Sulfamethoxazole Label ), AMPHOTERICIN B (View Amphotericin B Review and Amphotericin B Label ), VORICONAZOLE (View Voriconazole Review and Voriconazole Label ), CASPOFUNGIN (View Caspofungin Review and Caspofungin Label ). Patient was hospitalized.